$XOMA

Hughes Owen sold (to issuer) 102,000 shares of XOMA

Hughes Owen (Chief Executive Officer) sold (to issuer) 102,000 shares of XOMA Royalty Corp (XOMA) on 2026-07-14.

Original reporting
SEC EDGAR · Hughes Owen
Published Jul 15, 2026, 1:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 2:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$XOMA
Neutral
medium confidence
Mentioned
$XOMA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XOMANeutralLow
01

Why it matters

The newest fact is the CEO’s 102,000-share sale to the issuer on 2026-07-14, with holdings after the transaction reported as 0 shares.

02

Market read

Traders may monitor for follow-on insider activity or related corporate actions, but this single Form 4 does not provide fundamental performance information.

03

What to watch

No sale price is disclosed, and the CEO ends with 0 shares, which could reflect diversification or pre-planned mechanics rather than a new negative thesis.

Relevance 3/10Novelty 3/10Timing: after-hours Form 4 filed for 2026-07-14 transaction

Background

The article is an SEC Form 4 insider transaction disclosure for XOMA Royalty Corp.

Company-level read

Ticker impact

$XOMANeutralMedium confidence
Context

XOMA CEO Hughes Owen sold 102,000 shares to the issuer via Form 4, leaving 0 shares and signaling insider liquidity activity.

Expected impact

Likely limited, short-lived sentiment impact unless paired with other disclosures (buyback size, guidance, or operational news).

Evidence & confidence

The filing is a primary Form 4 disclosure, but the price is not disclosed and the transaction code D suggests a structured sale to the issuer rather than an open-market bearish bet.

Market effects

Minimal, as this is an issuer-specific insider transaction without sector-wide datapoints.

None indicated.

None indicated.

Counterpoint

Code D sales to the issuer can be routine (for example, buyback participation or plan mechanics), so the market may over-interpret it as bearish.

Key entities

  • XOMA Royalty Corp

    Company whose CEO insider transaction is disclosed on Form 4.

  • Hughes Owen

    Chief Executive Officer and director who sold 102,000 shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LGNDMedAI 9/10

XOMA Royalty Announces Closing of Its Acquisition by Ligand

XOMA Royalty said Ligand Pharmaceuticals (Nasdaq: LGND) completed its acquisition of XOMA Royalty. Under the April 27 deal, XOMA shareholders received $39.00 cash per share and one non-transferable CVR per share tied to 75% of net proceeds from certain pending litigation. XOMA shares no longer trade on Nasdaq.

$LAURMed

Snow Ian Kendell sold $19.1M of LAUR (indirect holdings)

Snow Ian Kendell sold 521,229 indirectly-held shares of LAUREATE EDUCATION, INC. (LAUR) at an average of $36.65 ($36.26–$38.43, $19.10M total) across 3 trades over 2026-08-31 to 2026-09-02. Filed jointly with Snow Phipps Group (RPV), L.P. (Director), Snow Phipps Group (Offshore), L.P. (Director), SPG Co-Investment, L.P. (Director), Snow Phipps Group (B), L.P. (Director), Snow Phipps Group, L.P. (Director) and Snow Phipps Group, LLC (Director).